5424-28-2 Usage
Explanation
The compound consists of 14 carbon atoms, 12 hydrogen atoms, 4 nitrogen atoms, and 2 oxygen atoms.
Explanation
The total mass of the molecular formula, calculated by adding the atomic weights of all the atoms in the compound.
Explanation
The compound has a ring structure containing both carbon and nitrogen atoms, making it a heterocyclic compound.
Explanation
1-benzyl-5,6-dihydro-1H-imidazo[4,5-d]pyridazine-4,7-dione is derived from the imidazo[4,5-d]pyridazine core structure.
Explanation
A benzyl group (C6H5CH2-) is attached to the 1-position of the imidazo[4,5-d]pyridazine core.
Explanation
The compound has been studied for its potential use in treating tumors and inflammation due to its biological activity.
Explanation
The compound's chemical structure and properties make it a valuable subject for further research and development in the field of medicinal chemistry.
Molecular Weight
284.27 g/mol
Structure
Heterocyclic ring
Derivative
Imidazo[4,5-d]pyridazine
Substituent
Benzyl group at the 1-position
Potential Pharmaceutical Applications
Anti-tumor and anti-inflammatory agent
Field of Research
Medicinal chemistry
Check Digit Verification of cas no
The CAS Registry Mumber 5424-28-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,4,2 and 4 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 5424-28:
(6*5)+(5*4)+(4*2)+(3*4)+(2*2)+(1*8)=82
82 % 10 = 2
So 5424-28-2 is a valid CAS Registry Number.
5424-28-2Relevant articles and documents
COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS
-
Page/Page column 38; 39, (2021/06/11)
The invention relates to a compound of Formula I, pharmaceutical compositions comprising a compound of Formula I, and methods of treating cystic fibrosis comprising the step of administering a therapeutically effective amount of a compound of Formula I to